BioNTech SE

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$1,518,900
$260,800
$182,800
$1,190,000
Gross Profit
1,370,600
184,400
99,000
946,500
EBITDA
149,299
-348,300
-368,700
464,400
EBIT
25,099
-399,300
-411,500
299,000
Net Income
-28,700
-386,600
-415,800
259,500
Net Change In Cash
1,518,900
260,800
182,800
1,190,000
Free Cash Flow
811,136
700,035
-1,472,185
-601,694
Cash
10,092,900
10,269,500
10,184,900
9,761,900
Basic Shares
239,166
241,625
240,346
240,277

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$2,751,100
$3,819,000
$17,310,600
$18,976,700
Gross Profit
2,209,800
3,219,200
14,315,600
16,065,200
EBITDA
-367,100
1,377,400
13,096,300
15,002,300
EBIT
-665,100
1,194,000
12,973,000
14,927,100
Net Income
-665,300
930,300
9,434,400
10,292,500
Net Change In Cash
2,751,100
3,819,000
17,310,600
18,976,700
Free Cash Flow
-244,600
4,665,900
13,214,100
735,700
Cash
9,761,900
11,663,700
13,875,100
1,692,700
Basic Shares
240,400
242,700
249,800
259,700

Earnings Calls

QuarterEPS
2025-12-31
$0
2025-09-30
-$0.12
2025-06-30
-$1.60
2025-03-31
-$1.82